Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-025389
Filing Date
2021-05-10
Accepted
2021-05-10 16:55:41
Documents
91
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_abvcbio.htm 10-Q 739476
2 CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION FILED ON FEBRUARY 17, 2021 f10q0321ex3-6_abvcbio.htm EX-3.6 1258
3 CERTIFICATION f10q0321ex31-1_abvcbio.htm EX-31.1 9366
4 CERTIFICATION f10q0321ex31-2_abvcbio.htm EX-31.2 9432
5 CERTIFICATION f10q0321ex32-1_abvcbio.htm EX-32.1 4523
6 CERTIFICATION f10q0321ex32-2_abvcbio.htm EX-32.2 4261
7 GRAPHIC ex10a_001.jpg GRAPHIC 390126
8 GRAPHIC ex10a_002.jpg GRAPHIC 263044
  Complete submission text file 0001213900-21-025389.txt   6530465

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE abvcd-20210331.xml EX-101.INS 871986
10 XBRL SCHEMA FILE abvcd-20210331.xsd EX-101.SCH 88169
11 XBRL CALCULATION FILE abvcd-20210331_cal.xml EX-101.CAL 39880
12 XBRL DEFINITION FILE abvcd-20210331_def.xml EX-101.DEF 337835
13 XBRL LABEL FILE abvcd-20210331_lab.xml EX-101.LAB 619642
14 XBRL PRESENTATION FILE abvcd-20210331_pre.xml EX-101.PRE 351526
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-91436 | Film No.: 21908084
SIC: 2834 Pharmaceutical Preparations